In an attempt to gain insight into the events that take place duringActinobacillus pleuropneumoniae infection, the present study was designed to ascertain the effects of bacterial toxicity on porcine neutrophil functions and viability. Incubation of phagocytes (2 x 106) with opsonized A. pleuropneumoniae 4074 (2 x 107 CFU) resulted in phagocytic uptake of <4%. At the same bacterium-to-phagocyte ratio, levels of lactate dehydrogenase activity of 74 and 81% were detected in the extracellular medium after 1.5 and 3 h of incubation, respectively.
Swine pleuropneumonia is a severe and economically important disease of pigs which is caused by the gramnegative bacterium Actinobacillus pleuropneumoniae (28, 40, 41) . The clinical course of the disease can be peracute, acute, subacute, or chronic, depending on the virulence of the infecting strain (36) , the infective dose (36, 42) , the immune status of the infected animal (29) , and stress caused by adverse environmental conditions (28, 39) . The peracute form of disease is characterized by an intense inflammatory reaction with increase in vascular permeability resulting in hemorrhage, edema, and fibrin exudation as well as infiltration of the lung parenchyma by neutrophils (3, 25) . Pneumonic lesions observed during the acute phase of disease consist of fibrinous pleuritis and multiple coalescing foci of coagulative necrosis surrounded by dense bands of degenerating leukocytes and unidentifiable round and elongated cells (25, 39) . Animals recovering from the acute disease usually develop the chronic form of disease, which is characterized by sequestrations of necrotic pulmonary tissue and pleuritic adhesions (28, 31, 41) . The chronically diseased animals usually exhibit high antibody titers and concomitant species-specific immunity (10, 30) but remain carriers of the bacterium and a source of infection for nonimmune animals (18) .
Whereas the clinical and histopathological manifestations of swine pleuropneumonia have been reasonably well clarified, the pathogenesis of A. pleuropneumoniae infection is not clearly defined at present. The capsular polysaccharide * Corresponding author. (CP) (17) , outer membrane protein(s) (48) , and lipopolysaccharide (LPS) endotoxin (49) have been implicated in the pathogenesis of this disease. However, antibodies directed against these cell wall components do not appear to mediate bacterial clearance from infected lungs, since formalintreated and heat-killed bacterins, which induce antibodies to these bacterial components, provide only minimal and serotype-specific protection against acute infection (10, 16, 29) . These observations indicate that some factor(s) produced by the viable bacteria may play a prominent role in the production of disease. This suggestion is consistent with reports which indicate that bacterium-free culture supernatant fluid and viable but not heat-killed A. pleuropneumoniae bacteria exhibit a dose-related cytotoxic effect on porcine neutrophils (37) , alveolar macrophages (2, 50) , and peripheral blood monocytes (2) . The most likely candidate for the toxicity associated with the viable bacteria is the heat-labile hemolysin which is secreted by most strains of A. pleuropneumoniae (37, 38) . However, the relevance of A. pleuropneumoniae toxicity to pulmonary clearance of invading bacteria by phagocytic cells is unclear.
Pulmonary clearance of infectious agents is critically dependent on the microbicidal activity of resident alveolar macrophages and recruited mononuclear and polymorphonuclear leukocytes (PMN) (19, 43) . The extent to which this major pulmonary defense mechanism is effective in removing A. pleuropneumoniae bacteria from infected lungs remains questionable in view of the cytotoxic activity of the viable bacteria for porcine phagocytes (2, 37, 50) . In an attempt to gain insight into the events that take place during A. pleuropneumoniae infection, we have examined the effects of bacterial toxicity on porcine PMN . After a 60-min incubation period at 37°C, the tubes were centrifuged (8,000 x g, 1 min) and the A545 of the supematants was measured. One hemolytic unit (HU) was defined as the amount of active hemolysin present in the dilution that resulted in lysis of 50% of the erythrocytes. The reference absorbance value for 50% lysis was determined by lysing erythrocytes contained in 0.25 ml of the cell suspension with 1 ml of water. The dilution corresponding to 50% lysis was determined by the two-point interpolation formula (20) by using the dilutions before and after 50% lysis to interpolate the exact 50% end point. The titer in HU per milliliter was expressed as the reciprocal of the dilution corresponding to 50% lysis, multiplied by two.
The level of cytolytic activity of the hemolysin preparation for porcine PMN (leukocidal activity) was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cleavage assay, which is based on the capacity of mitochondrial enzymes of viable cells to transform the dye into its dark-blue formazan derivative (27) Preparation of sera and polyclonal antibodies. Nonimmune swine serum (NSS) was prepared from blood obtained from five clinically healthy pigs with no known history of A. pleuropneumoniae infection. Preparation of the preimmune serum, NSS that was adsorbed with bacteria (NSS-A), and convalescent-phase serum (CS) has been described previously (48) . The CS was heated at 56°C for 30 min, pooled, filter sterilized, and stored at -20°C in 1-ml aliquots. Antibody to the CP was isolated from the CS by affinity chromatography as described previously (48) .
Polyclonal antibody to the hemolysin was raised in pigs which had been injected repeatedly with dialyzed and concentrated culture supernatant. Briefly, two 3-month-old pigs were injected intramuscularly with aliquots (200 ,ug) of the hemolysin preparation, which were emulsified in complete Freund's adjuvant. Booster To assess the capacity of each serum or polyclonal antibody to inhibit hemolysis, aliquots (250 pul; 4 HU/ml) of freshly prepared hemolysin were mixed with 250 of twofold serial dilutions of serum or the antibody solution (200 ,ug/ml) in TBCS and with 500 ,u of erythrocyte suspension (1%). After incubation at 37°C for 60 min, unlysed erythrocytes were removed by centrifugation (8,000 x g, 1 min) and the A545 of the supernatants was measured. The neutralizing titer was expressed as the reciprocal of the serum or antibody dilution required to achieve a 50% reduction in the hemolytic activity of the 1.0-HU sample.
The capacity of the sera and antibody preparations to inhibit leukocidal activity was determined in a similar manner. Aliquots (50 pA; 20 U/ml) of the hemolysin were mixed with 50 pl of twofold serial dilutions of serum or antibody solution (200 ,ug/ml) and with 100 ,lI of PMN suspension (5 x 106 cells per ml) in wells of microtiter plates. After 60 min of incubation at 37°C, 20 ,ul of MTT solution (5 mg/ml) was added to each well. Percent cytolysis was determined as described above. The neutralizing titer was expressed as the reciprocal of the serum or antibody dilution which caused a 50% reduction in leukocidal activity of the 1.0-U/ml sample.
Phagocytosis assay. An overnight culture ofA. pleuropneumoniae 4074 or E. coli was prepared by inoculating 20 ml of BHI-NAD with reconstituted lyophilized cultures and incubating the fresh cultures at 37°C overnight. On the morning of the assay, 0.2 ml of the overnight culture was transferred to 10 ml of fresh BHI-NAD containing 50 ,ul of methyl [3H]thymidine (specific activity, 50 to 80 Ci/mmol; Amersham Corporation, Arlington Heights, Ill.). The bacteria were grown for 2.5 h at 37°C with shaking (100 rpm) until a cell density of 5 x 108 CFU/ml was reached as determined by turbidity in a colorimeter (Klett-Summerson). Turbidity had been previously correlated with direct enumeration of CFU. The radiolabelled bacteria were washed once in Veronal-buffered saline solution (VBS) (pH 7.4) and suspended in VBS at a final concentration of 2 x 109 CFU/ml as determined by turbidity and confirmed by CFU determinations.
The radiolabelled bacteria were opsonized in a reaction mixture consisting of 100 (2 x 108 CFU) of bacterial suspension, 200 RI of NSS-A as a source of complement, 100 of different dilutions of CS or anti-CP, and 600 of VBS containing 0.15 mM CaCl2, 0.5 mM MgCl2, and 0.5% BA. Opsonization was performed for 30 min in a 37°C shaking water bath (60 rpm), after which the bacteria were pelleted by centrifugation (10,000 x g, 10 min, 10°C) and washed two times in VBS. The opsonized bacteria were suspended in VBS containing 0.5% BA (VBS-BA) to a final concentration of 108 CFU/ml as determined by turbidity and confirmed by colony counts.
Samples (200 pul; 2 x 107 CFU) of the opsonized, radiolabelled bacteria were mixed with 200 of the PMN suspension (2 x 106 cells) in microcentrifuge tubes to attain a final bacterium-to-phagocyte ratio of 10:1. In some experiments, 20-pul samples of the bacterial suspension (2 x 106 CFU) were mixed with 200 pI of the PMN suspension in order to achieve a bacterium-to-phagocyte ratio of 1:1. In other experiments, 100-pA aliquots of antihemolysin solution (200 ptg/ml) were added to the PMN suspension prior to mixing with the bacterial suspension. The final volume of the phagocytic mixtures was brought to 1.0 ml with HBSS-BA. Six phagocytic mixtures were prepared for bacteria that were opsonized at each concentration of antibody or serum.
As controls, two tubes were incubated at 4°C in order to distinguish between bacterial adhesion to PMN and active ingestion, since incubation at this temperature prevents bacterial ingestion (1). The remaining tubes were incubated at 37°C with shaking (100 rpm). After 60 min of incubation, two tubes were centrifuged at 10,000 x g for 10 min to sediment bacteria (total bacteria) and phagocytes. (20 ,ug) . In some experiments, PMN were exposed to different doses of hemolysin for 15 min prior to incubation with opsonized E. coli. After incubation at 37°C for 10 min with shaking (100 rpm), phagocytic ingestion was stopped by shaking the tubes in an ice-water bath for 1 min. Noningested bacteria were removed by differential centrifugation (200 x g, 5 min, 23°C) and two washes in PBS (15 ml per wash). The phagocytes and intracellular bacteria were suspended in 1.0 ml of HBSS-BA and incubated at 37°C in a shaking water bath (60 rpm). At designated intervals, 0.1-ml samples were removed, added to 9.9 ml of ice-cold distilled water containing 0.5% BA, and mixed vigorously in a vortex mixer for 3 min in order to disrupt the phagocytes. Serial 10-fold dilutions were made in PBS, and 10-,ul aliquots were plated on BHI agar supplemented with 0.01% NAD for determination of numbers of viable intracellular bacteria.
Lactate dehydrogenase release assay. The viability of PMN incubated with opsonized bacteria was determined by the lactate dehydrogenase sLDH) release assay (1 Hydrogen peroxide (H202) was measured by the horseradish peroxidase-mediated oxidation of phenol red as described by Pick and Keisari (32) . Briefly, 200-,ul samples (2 x 106 cells) of untreated and hemolysin-treated PMN suspensions were added to 800 RlI of phenol red-free HBSS containing 1 ,ug of PMA, 0.28 mM phenol red, and 10 U of horseradish peroxidase in microcentrifuge tubes. Assay tubes were rotated end over end (15 rpm) at 37°C for 1 h and then centrifuged (800 x g, 5 min). The supernatant fluids were transferred to microcentrifuge tubes containing 10 ,u of NaOH (1 M). The A610 was measured against a blank of 1 ml of phenol red solution in HBSS to which a 10-,ul quantity of NaOH (1 M) was added. With the use of a standard curve, the measured changes in the A610 were converted to quantities of H202 produced. The standard curve was constructed by measuring the absorbance of solutions containing horseradish peroxidase (10 U), 0.28 mM phenol red, and different concentrations of freshly diluted H202 in phenol red-free HBSS.
Statistical analysis. The data obtained from the phagocytosis, LDH release, and intracellular killing assays were analyzed by the Student t test. Relationships between hemolysin concentration and PMN oxidative metabolism or viability were determined by linear regression analysis after the independent variable was transformed in order to linearize the data.
RESULTS
Characterization of hemolysin preparation and polyclonal antibody. The use of a chemically defined medium for hemolysin production enabled us to obtain hemolysin preparations which were essentially free of exogenous proteins and macromolecules present in other complex media. In addition, the relatively short incubation period of the midlogarithmic-phase bacteria in the medium contributed to the absence of proteolytic degradation products in the hemolysin preparations. The preparations obtained under these growth conditions typically contained 3.0 ,ug of protein, (Fig. 1 ). Although staining with silver stain revealed additional low-molecular-weight bands (data not shown), it is not clear whether these additional bands are due to the contaminating LPS or membrane proteins which may be present in very small amounts.
Phagocytic ingestion. Initial experiments designed to evaluate phagocytic ingestion of E. coli and A. pleuropneumoniae 4074 showed that PMN incubated with opsonized A. pleuropneumoniae 4074 bacteria exhibited signs of clumping and degeneration, whereas those incubated with opsonized E. coli bacteria appeared normal. In view of the dose relationship between viable A. pleuropneumoniae and toxicity for porcine phagocytes (2, 38), the effect of bacterial density on phagocytic ingestion was examined. Table 1 depicts the results of experiments conducted with 2 x 106 PMN and 2 x 107 CFU (bacterium-to-phagocyte ratio of 10:1) as well as of those performed with 2 x 106 PMN and 2 x 106 CFU (bacterium-to-phagocyte ratio of 1:1). At the bacterium-to-phagocyte ratio of 10:1, 58% of the E. coli bacteria opsonized in 10% NSS was ingested by the PMN whereas uptake of A. pleuropneumoniae 4074 opsonized in NSS-A, NSS, or NSS-A plus CS was only marginal. Reduc observed for E. coli at the bacterium-to-phagocyte ratio of 10:1 (P < 0.001).
In order to determine whether the limited ingestion of A. pleuropneumoniae 4074 might be due to toxicity associated with the bacteria, samples of opsonized bacteria were assayed for phagocytic ingestion at the bacterium-to-phagocyte ratio of 10:1, in the absence or presence of antibody to the hemolysin. As shown in Table 2 , uptake of the bacteria in the presence of toxin-neutralizing antibody (20 ,g of protein) was significantly higher than that observed in the absence of the antibody (P < 0.001), irrespective of the type of serum or antibody concentration with which the bacteria were opsonized. Furthermore, in the presence of toxinneutralizing antibody, uptake of the bacteria that were opsonized in NSS-A plus CS or anti-CP was significantly higher than uptake of the bacteria that were opsonized in NSS-A or NSS (P < 0.01).
Viability of PMN interacting with opsonized bacteria. To confirm that the limited ingestion of A. pleuropneumoniae 4074 in the absence of antihemolysin was secondary to bacterially induced cytolysis of the PMN, the viability of the phagocytes interacting with opsonized bacteria was assessed by measuring LDH activity present in the supernatant. After 1.5 and 3 h of incubation, the amounts of LDH released from PMN incubated with opsonized E. coli were 12 and 20% of that of the control, respectively ( Table 3 ). The amounts released from the phagocytes incubated with opsonized heat-killed A. pleuropneumoniae 4074 after the same two intervals were 11 and 15% of control, respectively. In contrast, the amounts of LDH released from PMN interacting with viable A. pleuropneumoniae 4074 were 74 and 81% of that of the control after 1.5 and 3 h of incubation, respectively. The presence of toxin-neutralizing antibody (20 pg of protein) resulted in significantly less LDH release than that observed in the absence of the antibody (P < 0.001). Since the amount of LDH release is indicative of overt cytolysis, these data indicate that the interaction between PMN and viable A. pleuropneumoniae 4074 results in PMN cytolysis which can be prevented by adding antibody to the hemolysin. Addition of NSS (1 to 10%) or CS (2%) to the mixture of PMN and opsonized A. pleuropneumoniae 4074 also resulted in less LDH release than the amount released in the absence of the sera.
Bactericidal activity of PMN for ingested bacteria. To ascertain the extent to which PMN are capable of killing phagocytized bacteria, the phagocytes were allowed to ingest opsonized bacteria for 10 min in the absence or presence of toxin-neutralizing antibody. The number of intracellular CFU remaining after various intervals was then determined. As shown in Fig. 2 , E. coli bacteria ingested in the absence of antihemolysin were readily killed; the CFU of the intracellular bacteria declined by approximately 5.5 log1o units after 3 h of incubation. In contrast, A. pleuropneumoniae 4074 bacteria phagocytized in the absence of antihemolysin did not exhibit a reduction in CFU; instead, the CFU increased during the 3-h incubation period. The number of CFU of A. pleuropneumoniae 4074 ingested in the presence of toxin-neutralizing antibody (20 ,ug/ml) decreased by 0.9 log1o units at the end of the 3-h assay. However, this reduction was significantly less than that observed for intracellular E. coli (P < 0.01).
To obtain further evidence for the involvement of hemolysin in the inability of PMN to phagocytize and kill ingested bacteria, phagocytes were exposed to different doses of active and heat-inactivated hemolysin (100°C, 5 min), and then the bactericidal activity of the phagocytes for E. coli was assessed. As shown in Fig. 3 , control PMN which were treated with heat-inactivated hemolysin exhibited adequate bactericidal activity for E. coli. Approximately 25% uptake of the bacteria was observed at the initiation of the intracellular killing assay. The number of intracellular CFU was reduced by 3.5 + 0.21 log1o units at the end of the 2-h assay.
In contrast, PMN exposed to 2.0 HU of active hemolysin ingested only 5.7% of the opsonized bacteria. The ingested bacteria were not killed; the number of CFU did not decline but rather increased by 0.48 log1o at the end of the 2-h incubation period. The viability of these phagocytes was <15%, as determined by the MIT dye assay. Phagocytes treated with 0.2 HU of active toxin ingested up to 10% of the bacteria and killed only a small fraction of the ingested bacteria, but the reduction in number of CFU after 2 h of incubation (0.8 log1o) was significantly less than that observed for the control (P < 0.01).
Effect of hemolysin on PMN oxidative metabolism. To ascertain the effects of isolated hemolysin on PMN oxidative metabolism, the phagocytes were incubated with different doses of hemolysin for 15 min, after which their ability to generate 02 and H202 in response to PMA was assessed.
The viability of the toxin-treated phagocytes was also evaluated by the MIT dye assay in order to ascertain what doses of the toxin are cytolytic. As shown in Table 4 , exposure of Correlations between these doses of hemolysin and viability or reduction in oxygen metabolites produced were highly significant (P < 0.001). Phagocytes exposed to sublytic doses of hemolysin produced quantitatively similar amounts of H202 and more 02-than the unexposed control cells. Superoxide anion and H202 produced by PMN that were incubated with heat-inactivated hemolysin were quantitatively comparable to those generated by control cells (data not shown).
In order to determine whether the increase in 02 produced by PMN exposed to sublytic doses of hemolysin was (14, 27) , respectively. The results of the 02 assays indicated that sublytic doses of hemolysin (c0.05 HU) did not affect 02-production by the PMN unless PMA was present (data not shown). In contrast, sublytic doses of hemolysin caused dose-dependent increases in formazan formed by the toxin-treated phagocytes, compared with control cells which were incubated in TBCS buffer (Fig. 4) . Heat-inactivated hemolysin in concentrations comparable to sublytic doses of active toxin did not affect formazan formation. However, higher concentrations of the heated toxin caused increased formazan formation.
DISCUSSION
Phagocytosis and the subsequent killing of internalized bacteria by phagocytes constitute major pulmonary defense mechanisms (19, 35, 43) . The killing process involves a complex sequence of events which is initiated by directed migration of phagocytes to the site of infection (chemotaxis) (35, 43) . After attachment of the phagocytes to the bacteria, usually in concert with complement and antibodies directed against the bacterial surface antigenic determinants, the bacteria are engulfed into phagosomes (phagocytosis) and killed through the actions of toxic oxygen radicals generated during the respiratory burst (oxygen-dependent bactericidal activity) and by bactericidal components of the lysosomes (oxygen-independent activity) (35) . Because large numbers of PMN are present in the alveoli during the peracute phase of porcine pleuropneumonia (3, 25) , it is evident that chemotaxis is not impaired. However, the degenerate nature of these phagocytes during later phases of infection (25, 39) indicates that phagocytic ingestion and intracellular killing of A. pleuropneumoniae may be defective, apparently as a result of bacterial toxicity. In order to test this hypothesis, we have examined the in vitro effects of viable A. pleuropneumoniae 4074 and bacterium-free culture supernatant on the viability and respiratory-burst activity of porcine PMN as well as the ability of the phagocytes to phagocytize and effectively kill ingested bacteria. Lo92 The present study revealed that hemolysin produced byA. pleuropneumoniae 4074 can inhibit phagocytosis and intracellular killing of optimally opsonized A. pleuropneumoniae 4074 by virtue of its cytolytic activity against PMN. These observations are in contrast to those noted for the control, nonhemolytic E. coli, which was included in each experiment to ensure that each batch of PMN used in these assays was capable of phagocytosis and intracellular killing. The pivotal role of hemolysin in these events became apparent from several considerations. First, hemolysin-neutralizing antibody inhibited release of the cytosolic LDH, indicating that the antibody is capable of preventing bacterium-induced overt cell damage. Second, the antibody-protected PMN were able to ingest a significantly higher percentage of opsonized bacteria than phagocytes which were not protected by antibody to the hemolysin (P < 0.001). Furthermore, intracellular bacteria ingested in the presence of antihemolysin exhibited reduction in CFU, in contrast to those ingested in the absence of the antibody. Third, exposure of PMN to cytolytic doses of hemolysin resulted in a dose-related loss of cell viability, reduced bactericidal activity, and decreased capacity to undergo respiratory-burst activity. These observations imply that resistance of A. pleuropneumoniae to PMN bactericidal activity may be secondary to hemolysin-induced cytolysis. In the latter experiments, the possibility of contaminating endotoxin af-fecting these events was excluded through the use of heated hemolysin preparations which did not produce effects similar to those caused by the active toxin. Furthermore, in concentrations similar to those present in the hemolysin preparations, purified endotoxin was not cytolytic for PMN and did not have detectable effects on the bactericidal activity of the phagocytes (data not shown). These findings do not, however, exclude the possibility of cooperative effects between A. pleuropneumoniae endotoxin and hemolysin in vivo.
Our observation of limited phagocytic ingestion of A. pleuropneumoniae 4074 in the absence of hemolysin-neutralizing antibody appears contradictory to the report of Inzana et al. (17) , which showed uptake of 36.3 to 37.3% for A. pleuropneumoniae strains that were opsonized in homologous antiserum and presented to PMN at a bacterium-tophagocyte ratio of 80:1. This discrepancy is apparently due to the noncytotoxic nature of strain K17 (37, 38) and its acapsular derivative, which these authors studied. Nevertheless, in agreement with their report, our data indicate that antibody to CP is required for effective phagocytic ingestion of encapsulated A. pleuropneumoniae strains. Whereas antibodies to CP and hemolysin may mediate effective phagocytic ingestion of cytotoxic and encapsulated A. pleuropneumoniae strains in convalescent animals, the situation should be different in the nonimmune host which lacks these antibodies. The data derived from our phagocytosis assays implied that PMN are capable of ingesting a small fraction of A. pleuropneumoniae 4074 that was opsonized in preimmune serum and presented to the phagocytes in low numbers, in the absence of antihemolysin. This observation is consistent with the dose relationship between bacterial number and cytotoxic effect on phagocytes (2, 50). This observation is also in agreement with the results of our previous study, which indicate that C3b is formed and bound to A. pleuropneumoniae 4074 during opsonization in preimmune serum (48) . The uptake of bacteria opsonized in preimmune serum and presented to phagocytes in low numbers apparently was mediated by C3b in conjunction with antibodies to surfaceexposed epitopes on membrane proteins, which may be present in NSS (8, 34) . This suggestion is consistent with recent preliminary evidence which indicates that antibodies to surface-exposed epitopes on membrane proteins can act as opsonins for phagocytosis of A. pleuropneumoniae 4074 by PMN (46) .
Although antibody to the hemolysin prevented PMN cytolysis and significantly increased phagocytic ingestion ofA. pleuropneumoniae 4074 (P < 0.001), the data derived from the intracellular killing assays implied that the antibodyprotected phagocytes did not kill ingested A. pleuropneumoniae 4074 effectively, compared with intracellular E. coli. These observations raise the possibility that the inadequate bactericidal activity of the PMN for intracellular A. pleuropneumoniae 4074 may be due to de novo hemolysin and/or other factors produced by the bacteria in their new environment. The ability of ingested hemolytic bacteria to secrete de novo hemolysin has been shown to promote their intracellular survival and replication in cultured phagocytes (12, 33) . Other investigators have suggested that de novo hemolysin secreted by ingested bacteria may disrupt the phagosome membrane, thus allowing the intracellular bacteria to escape the hostile environment of the phagosome and replicate in the cytoplasm (13) . The possibilities that intracellular A. pleuropneumoniae could evade bactericidal mechanisms in the phagosome, replicate in the cytoplasm, and eventually produce cellular damage are consistent with our observations of time-dependent increase in LDH release from PMN that were incubated with viable bacteria in the presence of antihemolysin. These possibilities may also explain the incidence of chronic lesions in pigs vaccinated with the 107-kDa hemolysin and challenged with the bacterium (9) . These possibilities may also explain the persistent colonization of convalescent pig lungs in the presence of immunespecific antibodies.
There is now ample evidence that A. pleuropneumoniae hemolysin is related structurally to the pore-forming cytolysins produced by E. coli and certain gram-negative bacteria (51) . Like the E. coli hemolysin, A. pleuropneumoniae hemolysin appears to form transmembrane pores in target cells (22, 47) , implying that its mechanism of cellular damage might be similar to that of the E. coli hemolysin. Studies of the mechanism of cellular damage by the pore-forming cytolysins indicate that the transmembrane pores permit passive afflux of intracellular molecules, including ATP (4), as well as an influx of calcium ions (5) . The passive flux of calcium ions across toxin pores can trigger exocytotic processes such as the release of granule constituents from PMN (4) . The influx of calcium ions also represents a critical step in the induction of cell-specific, calcium-dependent cellular processes in cells exposed to hemolysin doses below the threshold of overt cell damage (44, 45) . In the present study, we observed that PMN exposed to sublytic doses of hemolysin in the presence of Ca2 , which were then stimulated with PMA, released more°2 than unexposed cells. This phenomenon was reflected in the results of the MTT cleavage assay, which showed that PMN incubated with sublytic doses of hemolysin produced more formazan than control cells which were incubated in TBCS buffer. Because the MTIT cleavage assay measures the number of viable cells and the metabolic state of cells (14, 27) , we believe that the increase in formazan formation reflects the increased activation levels of the toxin-treated cells. The ability of sublytic doses of A. pleuropneumoniae hemolysin to activate PMN may be related to the influx of Ca2+ through toxin pores. The resulting increase in cytosolic free calcium may promote translocation of protein kinase C from the cytosol to the membrane, thus sensitizing the cells to PMA. This suggestion is consistent with the recognition that increases in cytosolic free calcium may be intimately involved in the process of signal transduction during activation of the respiratory-burst NADH oxidase (23) .
In summary, the data presented herein indicate that A. pleuropneumoniae hemolysin is a potent antiphagocytic virulence determinant by virtue of its leucocidal activity.
The observations noted herein are fundamental to understanding the pathogenesis of A. pleuropneumoniae-induced swine pleuropneumonia.
